Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Sanofi
Engages in the research, production and distribution of pharmaceutical products

Sanofi engages in the research, production and distribution of pharmaceutical products.

It operates through the following segments: Pharmaceuticals, Human Vaccines, and Animal Health.

The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products.

This segment also includes equity affiliates and joint ventures with pharmaceutical business activities.

The Human Vaccines segment includes research, development, production and marketing of vaccines.

The Animal Health segment comprises the research, development, production and marketing activities for Merial, which offers a range of medicines and vaccines for animal species.

The company was founded on April 28, 1994 and is headquartered in Paris, France.
Sales per Businesses
20142015Delta
EUR (in Million)%EUR (in Million)%
Pharmaceuticals27,72082.1%29,79986.3% +7.5%
Vaccines3,97411.8%4,74313.7% +19.35%
Animal Health2,0766.1%---
Sales per Regions
20142015Delta
EUR (in Million)%EUR (in Million)%
United States11,33933.6%12,24635.5% +8%
Western Europe5,39116%5,24815.2% -2.65%
Latin America3,36310%3,0478.8% -9.4%
Asia (Excluding Pacific Region)3,2059.5%3,53610.2% +10.33%
Eastern Europe and Turkey2,5417.5%2,3666.8% -6.89%
France2,4747.3%2,2486.5% -9.14%
Japan2,1196.3%2,0345.9% -4.01%
Other1,1753.5%229.000.7% -80.51%
Rest of the World1,1003.3%1,3664% +24.18%
Middle East1,0633.1%---
Africa and Middle-East--2,2226.4%-
Managers
NameAgeSinceTitle
Olivier Brandicourt MD, PhD612015Chief Executive Officer & Director
Serge Weinberg662009Chairman
Jérôme Contamine602009Chief Financial Officer & EVP-Finance
Elias E. Zerhouni, MD662011President-Global Research & Development
Yong-Jun Liu MD, PhD-2016Head-Global Research & Development
Ameet Nathwani MD, MBA-2016Executive Vice President-Medical Affairs
Robert Castaigne, PhD712000Independent Director
Claudie Haigneré MD, PhD602008Independent Director
Carole Piwnica592010Independent Director
Suet-Fern Lee592011Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 1,287,105,713 1,156,997,968 89.9% 100,000 0.0% 89.9%
Shareholders
NameEquities%
L'Oréal SA 118,227,307 9.15%
Dodge & Cox 27,899,952 2.16%
Norges Bank Investment Management 26,541,076 2.05%
The Vanguard Group, Inc. 24,217,815 1.87%
Berkshire Hathaway, Inc. (Investment Management) 22,169,930 1.72%
Amundi Asset Management SA (Investment Management) 17,088,033 1.32%
Plan d'Epargne Entreprise Sanofi Synthelabo 16,697,049 1.29%
Lyxor International Asset Management SAS 13,243,760 1.03%
BlackRock Fund Advisors 12,973,063 1.00%
Natixis Asset Management SA 12,453,695 0.96%
Holdings
NameEquities%Valuation
Regeneron Pharmaceuticals Inc (REGN) 23,505,69422.7%8,445,360,797 USD
Aventis Pharma Limited (AVPH) 13,909,58760.4%841,658,677 USD
Alnylam Pharmaceuticals, Inc. (ALNY) 10,256,63312.0%410,162,754 USD
Sanofi (SAN) 3,956,7080.31%318,520,296 USD
Zentiva SA (ROSCD) 312,341,64974.9%147,693,872 USD
JHL Biotech Inc (6540) 28,415,11114.9%64,297,997 USD
Myokardia Inc (MYOK) 3,668,89911.7%41,091,669 USD
Voyager Therapeutics Inc (VYGR) 2,477,9419.26%29,537,057 USD
Regulus Therapeutics Inc (RGLS) 5,053,7799.55%6,064,535 USD
Proteome Sciences plc (PRM) 0
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
SANOFI4.38%109 628
JOHNSON & JOHNSON3.74%331 089
ROCHE HOLDING LTD.5.98%209 906
PFIZER INC.3.42%206 688
NOVARTIS AG3.51%201 806
MERCK & CO., INC.10.91%181 558
GLAXOSMITHKLINE PLC4.96%100 689
BRISTOL-MYERS SQUIBB C..-5.29%93 204
ALLERGAN PLC17.29%92 656
BAYER AG9.86%92 031
ELI LILLY AND CO10.22%91 131
ABBOTT LABORATORIES18.20%78 451
ASTRAZENECA PLC3.55%72 464
NOVO NORDISK A/S-3.02%71 264
SHIRE PLC3.65%55 496
TAKEDA PHARMACEUTICAL ..10.63%37 392
TEVA PHARMACEUTICAL IN..-2.96%36 240
ASTELLAS PHARMA INC-5.84%29 200
MYLAN NV10.96%22 651
CHUGAI PHARMACEUTICAL ..11.62%19 348
JIANGSU HENGRUI MEDICI..9.80%17 200
Sector Pharmaceuticals - NEC
Sanofi : Connections
Financières SASA
Académie des Technologies
Piasa Holding SAS
Piasa SA
Fondation C.Génial
Madrigall SA
Financière Piasa SAS
Weinberg Capital Partners SAS
Council on Foreign Relations, Inc.
Total Upstream UK Ltd.
Sanofi-Aventis Europe SAS
Fondation pour l’Université de Lyon
Sanofi-Aventis Participations SA
Financière Climater SAS
New York State Bar Association
Maremma SASU
Stamford Law Corp.
Sanofi-Aventis U.S. LLC
Rickmers Trust Management Pte Ltd.
National Committee on United States-China Relations, Inc.
AXA Group Solutions
Sanofi Pasteur Holding SA
Total Gestion Filiales
Sanofi Pasteur Holding Ltd.
Omnium Insurance & Reinsurance Co. Ltd.
Fondation Lacoste
Academie de l'air et de l'espace
L'Oréal Corporate Foundation
Naxos UK Ltd.
Academie des Sports
Research!America
Académie des Sciences et Technologies
King Abdullah University of Science & Technology
i2O Water Ltd.
Warp Drive Bio LLC
Elevance Renewable Sciences, Inc.
Select Music & Video Distribution Ltd.
Académie Nationale de Médecine
National Academy of Engineering
Big Red, Inc.
Institute of Medicine
NAXOS Capital Managers SARL
The Johns Hopkins University
Morgan Lewis Stamford LLC
MedImmune LLC
World Justice Project
Nanyang Technological University
International Bar Association
Stamford Corporate Services Pte Ltd.
International Federation of Pharmaceutical Manufacturers A
AXA Asia SAS
The Children's Aid Society, Inc.
Singapore Bar
Pharmaceutical Research & Manufacturers of America
Singapore Academy of Law
Company contact information
54 rue la Boétie
FR-75008 Paris
France

Phone : +33 (0)1 53 77 40 00
Fax : +33 (0)1 53 77 44 63
Internet : http://www.sanofi.com
Markets and indexes
- PEA / SRD eligible : YES / YES
- Euronext Paris
- Compartiment A
- CAC 40 / CAC All Shares, CAC All-Tradable, CAC Large 60, Euronext 100, EuroStoxx 50, FTSE Eurotop 100, Low Carbon 100 Europe, PEA, Stoxx Europe 50, Stoxx France 50, Stoxx Global 200
Stock Exchange Codes
- ISIN Code :  FR0000120578
- Bloomberg Code :  SAN:FP
- Reuters Code :  SASY.PA
- Datastream Code :  F:SQ@F
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem